Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

investor.regeneron.com

Regeneron Pharmaceuticals Inc. News Releases

Get the latest updates from Regeneron Pharmaceuticals Inc. News Releases directly as they happen.

Follow now 264 followers

Latest posts

Last updated 4 days ago

Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs

4 days ago

Oral presentation of Lynozyfic™ (linvoseltamab-gcpt) data in newly diagnosed multiple myeloma from...

Phase 2 Trials Demonstrating Antithrombotic Effect of Two Novel Regeneron Factor XI Antibodies Presented at American Heart Association Scientific Sessions and Published in The Lancet

9 days ago

Proof-of-concept trials confirm robust anti-clotting effects for Regeneron’s two mechanistically-distinct antibodies against...

Regeneron Announces Investor Conference Presentations

14 days ago

TARRYTOWN, N.Y. , Nov. 03, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...

Dupixent® (dupilumab) Wins Prestigious 2025 Prix Galien USA Best Biotechnology Product Award

17 days ago

Award recognizes the groundbreaking science of Dupixent and its transformational impact on...

Regeneron Reports Third Quarter 2025 Financial and Operating Results

20 days ago

Third quarter 2025 revenues increased 1% to $3.75 billion versus third quarter...

Regeneron to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on October 28, 2025

about 2 months ago

TARRYTOWN, N.Y. , Sept. 30, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc...

Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol

about 2 months ago

FDA approval extends the indication of Evkeeza to treat younger patients with...